课题基金 / 基金详情

Decoding a role for a natural killer cell-based immunotherapy in high-grade serous carcinoma within an engineered tumor microenvironment

Decoding a role for a natural killer cell-based immunotherapy in high-grade serous carcinoma within an engineered tumor microenvironment
解码基于自然杀伤细胞的免疫疗法在工程肿瘤微环境中对高级别浆液性癌的作用
批准号：
475359
负责人：
Pugh-Toole Morgan B
金额：
$7.65万
依托单位：
Dalhousie University (Nova Scotia)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475359&lang=en
关键词：
Combination Therapy High Grade Serous Carcinoma Immunotherapy Natural Killer Cells Ovarian Cancer Tumor Microenvironment

项目摘要

项目成果

Pugh-Toole Morgan B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
High-grade serous carcinoma (HGSC) is the deadliest form of ovarian cancer. It is often not diagnosed until it has grown a lot, and this can mean that treatment often fails, or tumors grow back. The current standard treatments -chemotherapy and surgery -
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Three Dimensional Evaluation of NK cell Prognostic Impact on High Grade Serous Ovarian Cancer
  • 批准号：
    467255
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2021
  • 负责人：
    Pugh-Toole Morgan B
  • 依托单位：
    Dalhousie University (Nova Scotia)
海外基金